Skip to content
Sign inOpen the app
Applied Clinical Trials

ACT Brief: FDA CRL Transparency Pause, Protocol-Centric Recruitment Model Shift, and Medical Affairs Integration in Development

July 13 · 1 min · 1.9 MB
0:00-1:58

Streams straight from the publisher. podnod never proxies or re-hosts episode audio.

Open in podnod
In today's ACT Brief, we examine the FDA's paused real-time complete response letter release policy, why programmatic patient engagement is replacing protocol-centric recruitment, and medical affairs' emerging role in bringing patient perspectives into clinical development.